PROGRAMMA - SIF

THURSDAY, October 15, 2009
P-1/1/14
P-1/1/15
P-1/1/16
P-1/1/17
P-1/1/18
P-1/1/19
P-1/1/20
P-1/1/21
ABSENCE OF ENDOGENOUS INTERLEUKIN-10 ENHANCES
SECONDARY INFLAMMATORY PROCESS AFTER SPINAL
CORD COMPRESSION INJURY IN MICE
Genovese T., Esposito E., Mazzon E., Di Paola R.,
Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S.
(Messina, Naples, Catania)
INTRAVENOUS MESENCHYMAL STEM CELLS
ADMINISTRATION INDUCES SURVIVAL AND SYMPTOM
AMELIORATION IN MUTANT SOD1 G93A MICE
Bonifacino T., Zappettini S., Milanese M., Casazza S.,
Caponnetto C., Uccelli A., Bonanno G. (Genoa)
FAILURE OF ATYPICAL ANTIPSYCHOTICS TO INDUCE
ANHEDONIA: BEHAVIOURAL EVIDENCE FOR THE ROLE OF
5-HT2 RECEPTORS
D'Aquila P., Cabras M., Modde C., Rassu C., Serra G.
(Sassari)
NEUROPROTECTIVE EFFECT OF
DEYDROEPIANDROSTERONE IN HEPATIC
ENCEPHALOPATHY: POSSIBLE INVOLVEMENT OF PROTEIN
KINASE C, EPSILON ISOFORM
Geminiani E., Corsi L., Carnevale G., Zanoli P., Baraldi M.
(Modena)
BB 16 AS NEW COMPOUND FOR MEMORY RELATED
DISORDERS
Di Viesti V., Carnevale G., Zavatti M., Zanoli P., Cannazza
G., Braghiroli D., Baraldi M. (Modena)
PHENOTYPICAL CHARACTERIZATION OF THIRD
TRIMESTER HUMAN AMNIOTIC FLUID CELLS: A NEW
RESERVOIR OF STEM CELLS?
Bottai D., Cigognini D., Nicora E., Ripamonti E., Adami R.,
Abrignani S., Moro M., Rebulla P., Menarini M., Di Giulio
A., Gorio A. (Milan, Imola)
THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH
POTENTIAL FOR THERAPY IN NEURODEGENERATIVE
DISORDERS
Cigognini D., Nicora E., Ripamonti E., Adami R., Menarini
M., Di Giulio A., Bottai D., Gorio A. (Milan, Imola)
ROLE OF MATRIX METALLOPROTEINASES IN RETINAL
GANGLION CELLS (RGCS) LOSS INDUCED BY RETINAL
ISCHEMIA/REPERFUSION
Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti
M., Bagetta G., Morrone L. (Cosenza, Catanzaro)
P-1/1/22 MELANOCORTINS PROTECT AGAINST CENTRAL AND
30
P-1/1/23
P-1/1/24
P-1/1/25
P-1/1/26
P-1/1/27
P-1/1/28
P-1/1/29
P-1/1/30
PERIPHERAL DAMAGE FOLLOWING CEREBRAL ISCHEMIA
THROUGH A VAGUS NERVE-MEDIATED MECHANISM
Giuliani D., Ottani A., Galantucci M., Minutoli L., Bitto A.,
Di Stefano V., Altavilla D., Squadrito F., Guarini S.
(Modena, Messina)
ROLE OF ENDOCANNABINOID SYSTEM AND VANILLOID
TRPV1 CHANNELS IN THE PHENOTYPE OF DOPAMINE D3
RECEPTOR KNOCK-OUT "D3(-/-)" MICE
Micale V., Cristino L., Tamburella A., Petrosino S., Leggio
G., Di Marzo V., Drago F. (Catania, Pozzuoli)
NOOTROPICS: "SMART DRUGS"?
Runci F., Fiaschi A., Barberi L., Passarello F.,
Montefrancesco G., Giorgi G. (Siena)
MOLECULES ACTING ON CB1 RECEPTOR AND THEIR
EFFECTS ON MORPHINE WITHDRAWAL IN VITRO
Festa M., Capasso A. (Salerno)
COMPARISON OF THE ANTIEPILEPTOGENIC EFFECTS OF
AN EARLY LONG-TERM TREATMENT WITH ETHOSUXIMIDE
OR LEVETIRACETAM IN A GENETIC ANIMAL MODEL OF
ABSENCE EPILEPSY
Russo E., Citraro R., Scicchitano F., Marra R., Donato Di
Paola E., De Fazio S., De Sarro G. (Catanzaro)
NEUROCHEMICAL AND BEHAVIORAL EFFECTS OF
CARVACROL
Zotti M., Avato P., Trabace L. (Foggia, Bari)
-LACTOALBUMIN, A WHEY PROTEIN RICH IN
TRYPTOPHAN, SHOWS EFFICACY IN RODENT MODELS OF
EPILEPSY
Citraro R., Russo E., Scicchitano F., De Fazio S., Marra R.,
Mainardi P., Perucca E., De Sarro G. (Catanzaro, Genoa,
Pavia)
LONG TERM ANTIEPILEPTIC DRUGS TREATMENT,
ABSENCE EPILEPSY AND DEPRESSION: A CORRELATION
STUDY
De Fazio S., Russo E., Citraro R., Scicchitano F., De Fazio
P., Segura Garcia C., Gareri P., De Sarro G. (Catanzaro)
EFFECTS OF FLAVONOIDS GENISTEIN AGLYCONE AND
FLAVOCOXID IN THE EXPERIMENTAL MOUSE MODEL OF
DUCHENNE MUSCULAR DYSTROPHY
Bitto A., Polito F., Irrera N., Messina S., Altavilla D.,
Guarini S., Caputi A. P., Squadrito F. (Messina, Modena)
P-1/1/31 MELATONIN REGULATES MATRIX METALLOPROTEINASE-2
31
THURSDAY, October 15, 2009